SCHEMBL7974010

SCHEMBL7974010

O=c1[nH]c(-c2cccc(Cl)c2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.53
ALDH1A1 P00352 2/20 0.53
KMT2A Q03164 1/20 0.53
HPGD P15428 1/20 0.51
CXCR2 P25025 1/20 0.46
PIN1 Q13526 2/20 0.45
ACP1 P24666 1/20 0.44
GLA P06280 1/20 0.43
HTT P42858 1/20 0.43
UBE2N P61088 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PGR P06401 2/20 0.43
GAA P10253 1/20 0.43
IDO1 P14902 1/20 0.42
PARN O95453 1/20 0.41
CNOT7 Q9UIV1 1/20 0.41
PNP P00491 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973624 0.96 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1KMT2AHPGDCXCR2
SCHEMBL7988662 0.94 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDCXCR2
SCHEMBL7975238 0.91 HPGD (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDACP1
SCHEMBL7985359 0.91 GRIN1 (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDACP1
SCHEMBL7988776 0.90 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDACP1
SCHEMBL7991594 0.90 HPGD (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDPIN1
SCHEMBL7988550 0.90 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDCXCR2
SCHEMBL7975265 0.90 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL7991564 0.89 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDACP1
SCHEMBL7984655 0.89 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed